Advancement in Heart Failure

 

The prevalence of heart failure (HF) continues to increase over time1 and affects >60 million people each year2.

 

Therefore, being aware of the latest data in the HF space and different treatment options is important in order to be able to apply findings to clinical practice when making treatment decisions for patients with type 2 diabetes mellitus (T2DM) and cardiovascular disease, especially HF.

Close X
Other videos you might like

This section is supported by the Boehringer Ingelheim & Lilly Alliance

Recent Videos

Video

DGK Berlin 2018: Die Rolle der Defibrillatorweste in der Klinischen Praxis
Lars S Maier

Video

DGK Berlin 2018
Andreas Fach

Video

TCT 2018: COAPT
Sameer Gafoor

Video

TCT 2018: REDUCE-FMR
Horst Sievert

Video

ESC 2018: PACT-HF
Harriette Van Spall

Video

ESC 2018: TIM-HF II Trial
Friedrich Koehler
Unmasking Adenosine: The Purinergic Signalling Molecule Critical to Arrhythmia Pathophysiology and Management

Arrhythmia & Electrophysiology Review 2019;8(4):240–8.

Ivabradine and AF: Coincidence, Correlation or a New Treatment?

Arrhythmia & Electrophysiology Review 2019;8(4):300–3.

Improving Cardiac Resynchronisation Therapy

Arrhythmia & Electrophysiology Review 2019;8(3):220–7.

Catheter Ablation for Atrial Fibrillation in Systolic Heart Failure Patients : Stone by Stone, a CASTLE

Arrhythmia & Electrophysiology Review 2018;7(4):265–72.

The Evolving Role of Catheter Ablation in Patients With Heart Failure and AF

Arrhythmia & Electrophysiology Review 2019;8(1):47–53.

Haemodynamic Monitoring Devices in Heart Failure: Maximising Benefit with Digitally Enabled Patient Centric Care

Arrhythmia & Electrophysiology Review 2018;7(4):294–8.

Atrial Fibrillation Ablation in Patients with Heart Failure: One Size Does Not Fit All

Arrhythmia & Electrophysiology Review 2018;7(2):84–90.

Treatment of Atrial Fibrillation in Patients with Coexisting Heart Failure and Reduced Ejection Fraction: Time to Revisit the Management Guidelines?

Arrhythmia & Electrophysiology Review 2018;7(2):91–4.

His Bundle Pacing: A New Frontier in the Treatment of Heart Failure

Arrhythmia & Electrophysiology Review 2018;7(2):103–10.

Sudden Cardiac Death and Arrhythmias

Arrhythmia & Electrophysiology Review 2018;7(2):111–7.

Letter to the Editor: His Bundle Pacing: A New Frontier in the Treatment of Heart Failure

Arrhythmia & Electrophysiology Review 2018;7(3):218.

A Review of Image-guided Approaches for Cardiac Resynchronisation Therapy

Arrhythmia & Electrophysiology Review 2017;6(2):69–74.

Is There a Future for Remote Cardiac Implantable Electronic Device Management?

Arrhythmia & Electrophysiology Review 2017;6(3):109–10.

The Role of Flecainide in the Management of Catecholaminergic Polymorphic Ventricular Tachycardia

Arrhythmia & Electrophysiology Review 2016;5(1):45–9

Pacing and Defibrillators in Complex Congenital Heart Disease

Arrhythmia & Electrophysiology Review 2016;5(1):57–64

Periodic Repolarisation Dynamics: A Natural Probe of the Ventricular Response to Sympathetic Activation

Arrhythmia & Electrophysiology Review 2016;5(1):31–6

Post-extrasystolic Potentiation: Link between Ca2+ Homeostasis and Heart Failure?

Arrhythmia & Electrophysiology Review 2016;5(1):20–6

The European Heart Rhythm Association: A Myriad of Benefits and Privileges

Arrhythmia & Electrophysiology Review 2016;5(2):82

A Clinical Perspective on Sudden Cardiac Death

Arrhythmia & Electrophysiology Review 2016;5(3):177–82

Atrial Fibrillation and Heart Failure: How Should We Manage Our Patients?

Arrhythmia & Electrophysiology Review 2016;5(3):162-3

ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy

Arrhythmia & Electrophysiology Review 2016;5(3):188–96

The Entirely Subcutaneous Defibrillator – A New Generation and Future Expectations

Arrhythmia & Electrophysiology Review 2015;4(2):116–21

Developments in Cardiac Resynchronisation Therapy

Arrhythmia & Electrophysiology Review 2015;4(2):122–8

Short QT Syndrome – Review of Diagnosis and Treatment

Arrhythmia & Electrophysiology Review 2014;3(2):76–9

Cardiac or Other Implantable Electronic Devices and Sleep-disordered Breathing – Implications for Diagnosis and Therapy

Arrhythmia & Electrophysiology Review 2014;3(2):116–9

Can we Modulate the Autonomic Nervous System to Improve the Life of Patients with Heart Failure? The Case of Vagal Stimulation

Arrhythmia & Electrophysiology Review 2014;3(2):120–2

Remote Monitoring for Follow-up of Patients with Cardiac Implantable Electronic Devices

Arrhythmia & Electrophysiology Review 2014;3(2):123–8

Sudden Unexplained Death – Treating the Family

Arrhythmia & Electrophysiology Review 2014;3(3):156–60

Cardiac Resynchronisation Therapy or MitraClip® Implantation for Patients with Severe Mitral Regurgitation and Left Bundle Branch Block?

Arrhythmia & Electrophysiology Review 2014;3(3):190–3

A Critical Reappraisal of the Current Clinical Indications to Cardiac Resynchronisation Therapy

Arrhythmia & Electrophysiology Review 2013;2(2):91-4

Use of Cardiac Resynchronisation Therapy - Change of Clinical Settings

Arrhythmia & Electrophysiology Review 2014;3(1):20-4

Current Evidence and Recommendations for Cardiac Resynchronisation Therapy

Arrhythmia & Electrophysiology Review 2014;3(1):9-14

Catheter Ablation of Atrial Fibrillation - Techniques and Technology

Arrhythmia & Electrophysiology Review, 2012;1(1):29–33

Defibrillation Testing During Defibrillator Implantation

Arrhythmia & Electrophysiology Review 2012;1(1):51–3

Body Surface Electrocardiographic Mapping for Non-invasive Identification of Arrhythmic Sources

Arrhythmia & Electrophysiology Review 2013;2(1):16-22

Premature Ventricular Complex-induced Cardiomyopathy

Arrhythmia & Electrophysiology Review 2018;7(2):128–34.

1.Heart disease and stroke statistics-2020 update: a report from the American Heart Association
Virani SS, Alonso A, Benjamin EJ, et al. Circulation 2020;141:e139-e596.
https://doi.org/10.1161/CIR.0000000000000757

2. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Lancet 2017;390:1211-59.
https://doi.org/10.1016/S0140-6736(17)32154-2